Figure 5 depicts contralateral tumor volumes over time in mice receiving the three most effective tumor treatments with either the combination of Ad-p53 + IL2 CD122/132, Ad-p53 + anti-PD-1, or Ad-p53 + IL2 CD122/132 + anti-PD-1. The gene discussed is TP53; the disease is neoplasm.